Crowdonomics
WatchlistPortfolio
Enosi Life Sciences Corp.

Reg CF · Common Stock · Jul 2021

ClosedReg CFCommon Equity
via Title3Funds LLC · last checked Sep 25, 2026
Raised
$0 / $1.1M max
0% of ceiling
Investors
—
—
Estimated pre-money
$27.5M
—

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
−$397K
FY2019
$0
−$1.1M
FY2020
RevenueNet income
Metric
FY2019 reviewed*
FY2020 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$397,306
-$1,068,482
Taxes paid
$0
$0
Balance sheet
Cash
$578
$161,839
Accounts receivable
$0
$0
Total assets
$1,187,974
$1,341,234
Short-term debt
$319,955
$50,425
Long-term debt
$45,401
$53,667
Total liabilities
$1,161,130
$104,092
Other
Headcount
0
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Est. pre-money$27.5M
Price / share$10.00
Shares offered10,000

Estimated, not stated: $10.00 × 2,750,000 securities outstanding as of Mar 2, 2021 (Form 1-A/A filed Mar 2, 2021).

Offering details

Target$100,000
Max$1,070,000
Min investment—
OpenedJul 20, 2021
DeadlineJul 19, 2022
ClosedJul 19, 2022
Days active364

Links & provenance

SEC filing
Source: SEC EDGAR
0001822263-21-000002
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.